Abstract:The aspartate-specific cysteine protease caspase-8 suppresses necroptotic cell death mediated by RIPK3 and MLKL. Indeed, mice that lack caspase-8 die in a RIPK3- and MLKL-dependent manner during embryogenesis<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="/articles/s41586-019-1548-x#ref-CR3">3</a>. In humans, caspase-8 deficiency is associated with immunodeficiency<a href="/articles/s41586-019-1548-x#ref-CR4">4</a> or very early onset inflammatory bowel disease<a href="/articles/s41586-019-1548-x#ref-CR5">5</a>. The substrates that are cleaved by caspase-8 to prevent necroptosis in vivo have not been defined. Here we show that knock-in mice that express catalytically inactive caspase-8(C362A) die as embryos owing to MLKL-dependent necroptosis, similar to caspase-8-deficient mice. Thus, caspase-8 must cleave itself, other proteins or both to inhibit necroptosis. Mice that express caspase-8(D212A/D218A/D225A/D387A), which cannot cleave itself, were viable, as were mice that express c-FLIP or CYLD proteins that had been mutated to prevent cleavage by caspase-8. By contrast, mice that express RIPK1(D325A), in which the caspase-8 cleavage site Asp325 had been mutated, died mid-gestation. Embryonic lethality was prevented by inactivation of RIPK1, loss of TNFR1, or loss of both MLKL and the caspase-8 adaptor FADD, but not by loss of MLKL alone. Thus, RIPK1(D325A) appears to trigger cell death mediated by TNF, the kinase activity of RIPK1 and FADD–caspase-8. Accordingly, dying endothelial cells that contain cleaved caspase-3 were abnormally abundant in yolk sacs of Ripk1D325A/D325A embryos. Heterozygous Ripk1D325A/+ cells and mice were viable, but were also more susceptible to TNF-induced cell death than were wild-type cells or mice. Our data show that Asp325 of RIPK1 is essential for limiting aberrant cell death in response to TNF, consistent with the idea that cleavage of RIPK1 by caspase-8 is a mechanism for dismantling death-inducing complexes.

K63-linked Ubiquitination Regulates RIPK1 Kinase Activity to Prevent Cell Death During Embryogenesis and Inflammation

Ubiquitination of RIPK1 Suppresses Programmed Cell Death by Regulating RIPK1 Kinase Activation During Embryogenesis.

Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.

Tyrosine Phosphorylation Regulates RIPK1 Activity to Limit Cell Death and Inflammation.

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

A unique death pathway keeps RIPK1 D325A mutant mice in check at embryonic day 10.5

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

RIP1 Kinase Activity-Dependent Roles in Embryonic Development of Fadd-deficient Mice

Crucial Roles of the RIP Homotypic Interaction Motifs of RIPK3 in RIPK1-Dependent Cell Death and Lymphoproliferative Disease

Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis

Regulatory mechanisms of RIPK1 in cell death and inflammation

ABIN-1 Regulates RIPK1 Activation by Linking Met1 Ubiquitylation with Lys63 Deubiquitylation in TNF-RSC

Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling

RIPK1 Dephosphorylation and Kinase Activation by PPP1R3G/PP1γ Promote Apoptosis and Necroptosis.

RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation

RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis

RIPK1 Plays a Crucial Role in Maintaining Regulatory T-Cell Homeostasis by Inhibiting Both RIPK3- and FADD-mediated Cell Death

25 years of research put RIPK1 in the clinic